Do nanoparticles provide a new opportunity for diagnosis of distal airspace disease?

International Journal of Nanomedicine

Volumn 12, Issue , 2017, Pages 41-51

  Löndahl, Jakob ^a,b   Jakobsson, Jonas Kf ^b   Broday, David M ^c   Aaltonen, H Laura ^d   Wollmer, Per ^d  

^a Department of Design Sciences   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^d LUND UNIVERSITY   (Sweden)

Author keywords

AiDA; COPD; Emphysema; Lung particle interaction; Nanoaerosols; Respiratory diagnosis

Indexed keywords

CARBON MONOXIDE; HEMOGLOBIN; NANOPARTICLE; AEROSOL; DIAGNOSTIC AGENT;

AEROSOL; ARTICLE; BREATHING; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC TEST; DIFFUSION; HUMAN; LUNG DISEASE; LUNG GAS EXCHANGE; LUNG STRUCTURE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; RESPIRATORY AIRFLOW; SPACE; TOTAL LUNG CAPACITY; INHALATIONAL DRUG ADMINISTRATION; LUNG; LUNG VOLUME; PARTICLE SIZE; PATHOLOGY; PATHOPHYSIOLOGY; PROCEDURES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SENSITIVITY AND SPECIFICITY; X-RAY COMPUTED TOMOGRAPHY;

ADMINISTRATION, INHALATION; AEROSOLS; DIAGNOSTIC USES OF CHEMICALS; DIFFUSION; HUMANS; LUNG; LUNG VOLUME MEASUREMENTS; MAGNETIC RESONANCE IMAGING; NANOPARTICLES; PARTICLE SIZE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATION; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 85007599977     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S121369     Document Type: Article

References (99)

1. WHO. Global Surveillance, Prevention and Control of Chronic Respiratory Diseases: A Comprehensive Approach. Geneva: World Health Organization; 2007.
2. van den Berge M, ten Hacken NH, Cohen J, Douma WR, Postma DS. Small airway disease in asthma and COPD: clinical implications. Chest. 2011;139(2):412-423.
3. Vestbo J, Hurd SS, Agusti AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013;187(4):347-365.
4. Fain SB, Panth SR, Evans MD, et al. Early emphysematous changes in asymptomatic smokers: detection with 3He MR imaging. Radiology. 2006;239(3):875-883.
5. Shaker SB, Stavngaard T, Hestad M, Bach KS, Tonnesen P, Dirksen A. The extent of emphysema in patients with COPD. Clin Respir J. 2009;3(1):15-21.
6. Bennett WD, Smaldone GC. Use of aerosols to estimate mean air-space size in chronic obstructive pulmonary disease. J Appl Physiol (1985). 1988;64(4):1554-1560.
7. Gebhart J, Heyder J, Stahlhofen W. Use of aerosols to estimate pulmonary air-space dimensions. J Appl Physiol Respir Environ Exerc Physiol. 1981;51(2):465-476.
8. Blanchard JD. Aerosol bolus dispersion and aerosol-derived airway morphometry: assessment of lung pathology and response to therapy, Part 1. J Aerosol Med. 1996;9(2):183-205.
9. Blanchard JD. Aerosol bolus dispersion and aerosol-derived airway morphometry: assessment of lung pathology and response to therapy, Part 2. J Aerosol Med. 1996;9(4):453-476.
10. Palmes ED. Use of aerosols to measure pulmonary dimensions. J Air Pollut Control Assoc. 1968;18(10):671.
11. Palmes ED. Measurement of pulmonary air spaces using aerosols. Arch Intern Med. 1973;131(1):76-79.
12. Broday DM, Georgopoulos P. Growth and deposition of hygroscopic particulate matter in the human lungs. Aerosol Sci Technol. 2001;34(1):144-159.
13. Heyder J. Assessment of airway geometry with inert aerosols. J Aerosol Med. 1989;2(2):89-97.
14. Rosenthal FS. Aerosol recovery following breathholding derived from the distribution of chordlengths in pulmonary tissue. J Aerosol Sci. 1989;20(2):267-277.
15. Brand P, Beinert T, Fruhmann G, Hillebrecht A, Heyder J. Aerosol derived airway morphometry at different levels of lung inflation. J Aerosol Med. 1993;6(3):165-176.
16. Blanchard JD, Heyder J, O’Donnell CR, Brain JD. Aerosol-derived lung morphometry: comparisons with a lung model and lung function indexes. J Appl Physiol (1985). 1991;71(4):1216-1224.
17. Zeman KL, Bennett WD. Measuring alveolar dimensions at total lung capacity by aerosol-derived airway morphometry. J Aerosol Med. 1995;8(2):135-147.
18. Brand P, Rieger C, Beinert T, Heyder J. Aerosol derived airway morphometry in healthy subjects. Eur Respir J. 1995;8(10):1639-1646.
19. Hankinson JL, Palmes ED, Lapp NL. Pulmonary air space size in coal miners. Am Rev Respir Dis. 1979;119(3):391-397.
20. Bennett WD, Smaldone GC. Human variation in the peripheral air-space deposition of inhaled particles. J Appl Physiol (1985). 1987;62(4):1603-1610.
21. Nikiforov AI, Lippmann M, Palmes ED. Validation of an in vivo aerosol probe technique by measurements of deposition and morphometry in excised human lungs. Ann Occup Hyg. 1988;32(inhaled particles VI):33-39.
22. Spektor DM, Hunt PR, Rosenthal F, Lippmann M. Influence of airway and airspace sizes on particle deposition in excised donkey lungs. Exp Lung Res. 1985;9(3-4):363-387.
23. Rahmel A, Schwalen A, Calzia E, Huber A, Schulz H, Meyer M. Aerosol-derived airway dimensions of dog lungs: comparison of bolus and single-breath techniques. Mohr U, Bates DV, Fabel H, Utell MJ, editors. In: Advances in Controlled Clinical Inhalation Studies. Ilsi Monographs. Springer-Verlag, Berlin: 1993:377-386.
24. Brand P, Selzer T, Tuch T, Schulz A, Heyder J. Accuracy and resolution power of aerosol-derived airway morphometry in a simple lung model. Exp Lung Res. 1994;20(3):185-205.
25. Zeman KL, Bennett WD. Growth of the small airways and alveoli from childhood to the adult lung measured by aerosol-derived airway morphometry. J Appl Physiol (1985). 2006;100(3):965-971.
26. Beinert T, Brand P, Behr J, Vogelmeier C, Heyder J. Peripheral airspace dimensions in patients with COPD. Chest. 1995;108(4):998-1003.
27. Brand P, Kohlhäufl N, Meyer T, Selzer T, Heyder J, Häussinger K. Aerosol-derived airway morphometry and aerosol bolus dispersion in patients with lung fibrosis and lung emphysema. Chest. 1999;116(2):543-548.
28. Kohlhäufl M, Brand P, Rock C, et al. Noninvasive diagnosis of emphysema. Aerosol morphometry and aerosol bolus dispersion in comparison to HRCT. Am J Respir Crit Care Med. 1999;160(3):913-918.
29. Lehnigk B, Schleiss M, Brand P, Heyder J, Magnussen H, Jörres RA. Aerosol-derived airway morphometry (ADAM) in patients with lung emphysema diagnosed by computed tomography-reproducibility, diagnostic information and modelling. Eur J Med Res. 2007;12(2):74-83.
30. Shaker SB, Maltbaek N, Brand P, Haeussermann S, Dirksen A. Quantitative computed tomography and aerosol morphometry in COPD and alpha1-antitrypsin deficiency. Eur Respir J. 2005;25(1):23-30.
31. Brand P, Letzel S, Buchta M, et al. Can aerosol-derived airway morphometry detect early, asymptomatical lung emphysema? J Aerosol Med. 2003;16(2):143-151.
32. Lehnigk B, Schleiss M, Bluhme P, et al. Aerosol-derived effective air space diameter (EAD) in different types of emphysema as characterized by computer tomography compared to healthy subjects. J Aerosol Med. 1995;8:126.
33. Lehnigk B, Schleiss M, Bluhme P, et al. Aerosol derived airway morphometry in emphysema and fibrosis. Am J Respir Crit Care Med. 1995;151:118.
34. Anderson PJ, Gann LP, Tennal K, Hiller FC. Airway caliber and function in restrictive lung disease. Am Rev Respir Dis. 1993;147(4):A451.
35. Meyer M, Rahmel AO. Aerosol-derived airway dimensions of dog lungs in histamine-induced bronchoconstriction. J Aerosol Sci. 1993;24(5):671-681.
36. Rahmel A, Meyer M. Airway dimensions during histamine-induced airway constriction in dogs. Ann Occup Hyg. 1994;38(inhaled particles VII):181-187.
37. Schiller-Scotland CF, Gebhart J, Lintl H, Siekmeier R, Kronenberger H. Human airway diameters derived from aerosol inhalation studies: reactions of non-smokers and smokers to bronchodilators. J Aerosol Sci. 1989;20(8):1305-1308.
38. Rosenthal FS. Aerosol deposition and dispersion characterize lung injury in a canine model of emphysema. J Appl Physiol (1985). 1995;78(4):1585-1595.
39. Schulz H, Schulz A, Brand P, et al. Aerosol bolus dispersion and effective airway diameters in mildly asthmatic children. Eur Respir J. 1995;8(4):566-573.
40. Broday D. Deposition of ultrafine particles at carinal ridges of the upper bronchial airways. Aerosol Sci Technol. 2004;38(10):991-1000.
41. Landahl HD. On the removal of air-borne droplets by the human respiratory tract: I. The lung. Bull Math Biophys. 1950;12(1):43-56.
42. Anderson PJ, Wilson JD, Hiller FC. Respiratory tract deposition of ultrafine particles in subjects with obstructive or restrictive lung disease. Chest. 1990;97(5):1115-1120.
43. Brown JS, Zeman KL, Bennett WD. Ultrafine particle deposition and clearance in the healthy and obstructed lung. Am J Respir Crit Care Med. 2002;166(9):1240-1247.
44. Löndahl J, Swietlicki E, Rissler J, et al. Experimental determination of the respiratory tract deposition of diesel combustion particles in patients with chronic obstructive pulmonary disease. Part Fibre Toxicol. 2012;9:30.
45. Möller W, Felten K, Sommerer K, et al. Deposition, retention, and translocation of ultrafine particles from the central airways and lung periphery. Am J Respir Crit Care Med. 2008;177(4):426-432.
46. Muala A. Diesel Exhaust and Wood Smoke Exposure: Mechanisms, inflammation and intervention. Umeå: Public Health and Clinical Medicine, Umeå University; 2014.
47. International Commission on Radiological Protection. Human Respiratory Tract Model for Radiological Protection: A Report of a Task Group of the International Commission on Radiological Protection. Oxford, NY: Pergamon; 1994.
48. Fazio F, Wollmer P, Lavender JP, Barr MM. Clinical ventilation imaging with In-113m aerosol: a comparison with Kr-81m. J Nucl Med. 1982;23(4):306-314.
49. Fleming J, Conway J, Majoral C, et al. Controlled, parametric, individualized, 2-D and 3-D imaging measurements of aerosol deposition in the respiratory tract of asthmatic human subjects for model validation. J Aerosol Med Pulm Drug Deliv. 2015;28(6):432-451.
50. Häussermann S, Acerbi D, Brand P, et al. Lung deposition of formoterol HFA (Atimos/Forair) in healthy volunteers, asthmatic and COPD patients. J Aerosol Med. 2007;20(3):331-341.
51. Ramanna L, Tashkin DP, Taplin GV, et al. Radioaerosol lung imaging in chronic obstructive pulmonary disease: comparison with pulmonary function tests and roentgenography. Chest. 1975;68(5):634-640.
52. Sweeney TD, Skornik WA, Brain JD, Hatch V, Godleski JJ. Chronic bronchitis alters the pattern of aerosol deposition in the lung. Am J Respir Crit Care Med. 1995;151(2 Pt 1):482-488.
53. Taplin GV, Tashkin DP, Chopra SK, et al. Early detection of chronic obstructive pulmonary disease using radionuclide lung-imaging procedures. Chest. 1977;71(5):567-575.
54. Macey DJ, Marshall R. Absolute quantitation of radiotracer uptake in the lungs using a gamma camera. J Nucl Med. 1982;23(8):731-734.
55. Kleinstreuer C, Zhang Z. Airflow and particle transport in the human respiratory system. Annu Rev Fluid Mech. 2010;42:301-334.
56. Rostami AA. Computational modeling of aerosol deposition in respiratory tract: a review. Inhal Toxicol. 2009;21(4):262-290.
57. Martonen T. Commentary ‘Effects of asymmetric branch flow rates on aerosol deposition in bifurcating airways’, by Z. Zhang, C. Kleinstreuer and C. S. Kim. J Med Eng Technol. 2001;25(3):124-127.
58. Xi J, Longest PW, Martonen TB. Effects of the laryngeal jet on nano-and microparticle transport and deposition in an approximate model of the upper tracheobronchial airways. J Appl Physiol (1985). 2008;104(6):1761-1777.
59. Farkas A, Balásházy I. Simulation of the effect of local obstructions and blockage on airflow and aerosol deposition in central human airways. J Aerosol Sci. 2007;38(8):865-884.
60. Xi J, Longest PW. Effects of oral airway geometry characteristics on the diffusional deposition of inhaled nanoparticles. J Biomech Eng. 2008;130(1):011008.
61. Zhang Z, Kleinstreuer C, Kim CS. Airflow and nanoparticle deposition in a 16-generation tracheobronchial airway model. Ann Biomed Eng. 2008;36(12):2095-2110.
62. Zhang Z, Kleinstreuer C, Donohue JF, Kim CS. Comparison of micro-and nano-size particle depositions in a human upper airway model. J Aerosol Sci. 2005;36(2):211-233.
63. Zhang Z, Kleinstreuer C, Kim CS. Comparison of analytical and CFD models with regard to micron particle deposition in a human 16-generation tracheobronchial airway model. J Aerosol Sci. 2009;40(1):16-28.
64. Sturm R. Theoretical models for the simulation of particle deposition and tracheobronchial clearance in lungs of patients with chronic bronchitis. Ann Transl Med. 2013;1(1):3.
65. Sturm R, Hofmann W. Stochastic simulation of alveolar particle deposition in lungs affected by different types of emphysema. J Aerosol Med. 2004;17(4):357-372.
66. Bennett WD, Zeman KL, Kim C, Mascarella J. Enhanced deposition of fine particles in COPD patients spontaneously breathing at rest. Inhal Toxicol. 1997;9(1):1-14.
67. Kim CS, Kang TC. Comparative measurement of lung deposition of inhaled fine particles in normal subjects and patients with obstructive airway disease. Am J Respir Crit Care Med. 1997;155(3):899-905.
68. Kim CS, Lewars GA, Sackner MA. Measurement of total lung aerosol deposition as an index of lung abnormality. J Appl Physiol (1985). 1988;64(4):1527-1536.
69. Love RG, Muir DC. Aerosol deposition and airway obstruction. Am Rev Respir Dis. 1976;114(5):891-897.
70. Schiller-Scotland CF, Gebhart J, Hochrainer D, Siekmeier R. Deposition of inspired aerosol particles within the respiratory tract of patients with obstructive lung disease. Toxicol Lett. 1996;88(1-3):255-261.
71. Hinds WC. Aerosol Technology: Properties, Behavior, and Measurement of Airborne Particles. 2nd ed. John Wiley & Sons, Inc; 1999.
72. Longest PW, Xi JX. Computational investigation of particle inertia effects on submicron aerosol deposition in the respiratory tract. J Aerosol Sci. 2007;38(1):111-130.
73. Macintyre N, Crapo RO, Viegi G, et al. Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J. 2005;26(4):720-735.
74. Grgic B, Martin AR, Finlay WH. The effect of unsteady flow rate increase on in vitro mouth-throat deposition of inhaled boluses. J Aerosol Sci. 2006;37(10):1222-1233.
75. Smaldone GC. Physiological and pathological considerations for aerosol deposition: expiration and models of deposition. J Aerosol Med. 2000;13(4):387-391.
76. Bennett WD, Smaldone GC. Inspiratory vs expiratory aerosol deposition in excised dog lungs. J Aerosol Sci. 1987;18(1):49-57.
77. Price OT, Asgharian B, Miller FJ, Cassee FR, de Winter-Sorkina R. Multiple Path Particle Dosimetry model (MPPD v1.0): a model for human and rat airway particle dosimetry. RIVM rapport 650010030. 2002.
78. Heyder J. Charting human thoracic airways by aerosols. Clin Phys Physiol Meas. 1983;4(1):29-37.
79. Palmes ED, Altshuler B, Nelson N. Deposition of aerosols in the human respiratory tract during breath holding. In: Davies CN; British Occupational Hygiene Society. Inhaled Particles and Vapours. 2nd ed. New York, NY: Symposium Publications Division, Pergamon Press; 1967:339-347.
80. Rosenthal FS. A model for determining alveolar and small airway dimensions from aerosol recovery data. J Appl Physiol (1985). 1985;58(2):582-591.
81. Heyder J. Gravitational deposition of aerosol particles within a system of randomly oriented tubes. J Aerosol Sci. 1975;6(2):133-137.
82. Gebhart J, Heyder J. Removal of aerosol particles from stationary air within porous media. J Aerosol Sci. 1985;16(2):175-187.
83. Goldberg IS, Smith RB. Settling and diffusion of aerosol particles in small airways during breath holding. Ann Biomed Eng. 1981;9(5-6):557-575.
84. Yu CP, Liu CS, Taulbee DB. Simultaneous diffusion and sedimentation of aerosols in a horizontal cylinder. J Aerosol Sci. 1977;8(5):309-316.
85. Tsuda A, Henry FS, Butler JP. Particle transport and deposition: basic physics of particle kinetics. Compr Physiol. 2013;3(4):1437-1471.
86. Hofemeier P, Sznitman J. Revisiting pulmonary acinar particle transport: convection, sedimentation, diffusion, and their interplay. J Appl Physiol (1985). 2015;118(11):1375-1385.
87. Fishler R, Hofemeier P, Etzion Y, Dubowski Y, Sznitman J. Particle dynamics and deposition in true-scale pulmonary acinar models. Sci Rep. 2015;5:14071.
88. Sznitman J. Respiratory microflows in the pulmonary acinus. J Biomech. 2013;46(2):284-298.
89. Johannessen A, Skorge TD, Bottai M, et al. Mortality by level of emphysema and airway wall thickness. Am J Respir Crit Care Med. 2013;187(6):602-608.
90. Stratelis G, Mölstad S, Jakobsson P, Zetterström O. The impact of repeated spirometry and smoking cessation advice on smokers with mild COPD. Scand J Prim Health Care. 2006;24(3):133-139.
91. Efferth T, Verdorfer I, Miyachi H, et al. Genomic imbalances in drug-resistant T-cell acute lymphoblastic CEM leukemia cell lines. Blood Cells Mol Dis. 2002;29(1):1-13.
92. de Lange EE, Mugler JP 3rd, Brookeman JR, et al. Lung air spaces: MR imaging evaluation with hyperpolarized 3He gas. Radiology. 1999;210(3):851-857.
93. Salerno M, Altes TA, Mugler JP 3rd, Nakatsu M, Hatabu H, de Lange EE. Hyperpolarized noble gas MR imaging of the lung: potential clinical applications. Eur J Radiol. 2001;40(1):33-44.
94. Mugler JP 3rd, Altes TA. Hyperpolarized 129Xe MRI of the human lung. J Magn Reson Imaging. 2013;37(2):313-331.
95. Kim CS, Jaques PA. Respiratory dose of inhaled ultrafine particles in healthy adults. Philos Trans A Math Phys Eng Sci. 2000;358(1775):2693-2705.
96. Landahl HD, Tracewell TN, Lassen WH. On the retention of airborne particulates in the human lung: II. AMA Arch Ind Hyg Occup Med. 1951;3(4):359-366.
97. Stoeger T, Reinhard C, Takenaka S, et al. Instillation of six different ultrafine carbon particles indicates a surface area threshold dose for acute lung inflammation in mice. Environ Health Perspect. 2006;114(3):328-333.
98. Jakobsson JKF, Hedlund J, Kumlin J, Wollmer P, Löndahl J. A new method for measuring lung deposition efficiency of airborne nanoparticles in a single breath. Scientific Reports. 2016;6:36147.
99. Löndahl J, Möller W, Pagels JH, Kreyling WG, Swietlicki E, Schmid O. Measurement techniques for respiratory tract deposition of airborne nanoparticles: a critical review. J Aerosol Med Pulm Drug Deliv. 2014;27(4):229-254.